Physician profile
Michael David Kreines
NPI 1194714907
$1,244.01
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $146 · 2021: $310 · 2022: $140.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $328.84 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $177.29 | 2019-2022 | |
| Pfizer INC. | $152.42 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $135.57 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $67.93 | 2021 | |
| Gilead Sciences, INC. | $60.00 | 2019-2020 | |
| Celgene Corporation | $55.24 | 2021-2022 | |
| Amgen INC. | $53.10 | 2020-2022 | |
| Qol Medical, LLC | $50.33 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $29.79 | 2019 | |
| Merck Sharp & Dohme LLC | $27.56 | 2019-2020 | |
| Ucb, INC. | $26.79 | 2019 | |
| Shire North American Group INC | $17.76 | 2019 | |
| Daiichi Sankyo INC. | $13.54 | 2019 | |
| Janssen Biotech, INC. | $12.61 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.13 | 2020 | |
| Ironwood Pharmaceuticals, INC | $11.78 | 2021 | |
| Boston Scientific Corporation | $11.33 | 2020 |
5 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kreines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.